For the quarter ending 2025-09-30, INDP has $6,840,052 in assets. $5,825,639 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 5,825,639 | 6,157,701 | ||
| Prepaid expenses and other current assets | 613,354 | 255,357 | ||
| Total current assets | 6,438,993 | 6,413,058 | ||
| Right-of-use asset | 8,487 | 33,577 | ||
| Other assets - deposits to third parties | 392,572 | 392,572 | ||
| Total non-current assets | 401,059 | 426,149 | ||
| Total assets | 6,840,052 | 6,839,207 | ||
| Accounts payable and other current liabilities | 2,225,639 | 1,975,687 | ||
| Operating lease liability, current portion | 8,686 | 34,373 | ||
| Fair value of convertible promissory notes (note 7) | - | 6,502,503 | ||
| Total current liabilities | 2,234,325 | 8,512,563 | ||
| Common stock 0.01 par value, 200,000,000 shares authorized as of september 30, 2025 and december 31, 2024 1,641,920 shares issued and outstanding as of september 30, 2025 and 428,799 shares issued and outstanding as of december 31, 2024 | 16,420 | 6,050 | ||
| Additional paid in capital | 77,764,956 | 68,521,126 | ||
| Accumulated deficit | -73,175,649 | -70,200,532 | ||
| Total stockholders equity | 4,605,727 | -1,673,356 | ||
| Total liabilities and stockholders equity | 6,840,052 | 6,839,207 | ||
Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc. (INDP)